Skip to content

The effect of Bigu on health outcomes in obese adults and metabolomics analysis

The effect of Bigu on health outcomes in obese adults and metabolomics analysis

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000040624
Enrollment
Unknown
Registered
2020-12-04
Start date
2020-12-10
Completion date
Unknown
Last updated
2021-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Interventions

Bigu group:Bigu
Fasting group:Calorie restriction

Sponsors

Wuhan Sports Universitys
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-60 years old; 2. BMI >=28 kg/m2

Exclusion criteria

Exclusion criteria: 1. Those who cannot complete the experimental documents required for this research; 2. Those who cannot engage in exercise intervention; 3. Have used or are using weight control drugs (such as orlistat, metformin, liraglutide) within 3 months 4. People with the following diseases (such as severe failure of the heart, liver, kidney, lung and other important organs, heart function above grade 3, diabetic complications such as ketoacidosis, severe hypertension (blood pressure>=180/ 110mmHg), chest X-ray or CT showed obvious lung disease such as severe lung infection, pneumonia or lung tumor. 5. Patients with endocrine diseases such as abnormal thyroid function that cannot be controlled or patients with a history of epilepsy; 5. Severe mental illness (such as major depressive disorder, bipolar disorder, schizophrenia); 6. Women during pregnancy.

Design outcomes

Primary

MeasureTime frame
Height;Weight;BMI;Waist circumference;Hip circumference;Fasting blood glucose;Blood lipids;

Secondary

MeasureTime frame
Liver function;Kidney function;Glycated hemoglobin;Blood uric acid;Body composition;Heart rate;

Countries

China

Contacts

Public ContactAiqiao Shi

Wuhan Sports University

saiqiao@163.com+86 13907180144

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026